A study for a 79 year old woman who takes Xarelto, Methocarbamol - from FDA reports


12 females aged 79 (±5) who take the same drugs are studied. This is a personalized study for a 79 year old female patient who has A-Fib, Muscle Spasm. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.




On Dec, 13, 2018

12 females aged 79 (±5) who take Xarelto, Methocarbamol are studied.


Number of reports submitted per year:

Xarelto, Methocarbamol for a 79-year old woman.

Information of the patient in this study:

  • Age: 79
  • Gender: female
  • Conditions: A-Fib, Muscle Spasm
  • Drugs taken:
    • Xarelto (rivaroxaban)
    • Methocarbamol (methocarbamol)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Rectal haemorrhage (bleeding from anus)
  3. Weight decreased
  4. High blood pressure
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Anaemia (lack of blood)
  7. Haemorrhagic arteriovenous malformation (abnormal connection between the arteries and veins in the brain with bleeding)
  8. Haematoma (collection of blood outside the blood vessels)
  9. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
1 - 6 months:
  1. Acute myocardial infarction (acute heart attack)
  2. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  3. Haematochezia (passage of stools containing blood)
  4. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
6 - 12 months:
  1. Heart attack
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
1 - 2 years:
  1. Heart attack
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Fall
  3. Rectal haemorrhage (bleeding from anus)
  4. Arthropathy
  5. Femur fracture
  6. Heart attack
  7. Itching
  8. High blood pressure
  9. Acute myocardial infarction (acute heart attack)
  10. Gastric ulcer haemorrhage (bleeding ulcer of stomach)

Top conditions involved for these people *:

  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 25.00%
  2. Pain : 3 people, 25.00%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 16.67%
  4. Preventive Health Care : 2 people, 16.67%
  5. Pain In Extremity : 2 people, 16.67%
  6. Neuropathy Peripheral (surface nerve damage): 2 people, 16.67%
  7. Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 2 people, 16.67%
  8. Cardiac Disorder : 2 people, 16.67%
  9. Bladder Disorder : 2 people, 16.67%
  10. Stress And Anxiety : 1 person, 8.33%

Top co-used drugs for these people *:

  1. Lyrica (4 people, 33.33%)
  2. Nitrostat (3 people, 25.00%)
  3. Baby Aspirin (3 people, 25.00%)
  4. Vitamin D3 (2 people, 16.67%)
  5. Miralax (2 people, 16.67%)
  6. Clopidogrel (2 people, 16.67%)
  7. Flomax (2 people, 16.67%)
  8. Protonix (2 people, 16.67%)
  9. Ranexa (2 people, 16.67%)
  10. Solu-Medrol (2 people, 16.67%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!